| Stage | CVNA | % of rev | AN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $7.0B | 100.00% | CVNA ×1.14 |
| Gross profit | $1.5B | 18.92% | $1.2B | 17.41% | CVNA +1.5pp |
| Operating income | $714M | 8.88% | $315M | 4.48% | CVNA +4.4pp |
| Pre-tax income | $552M | 6.87% | $216M | 3.07% | CVNA +3.8pp |
| Net income | $483M | 6.01% | $162M | 2.31% | CVNA +3.7pp |
| Stage | CVNA | AN | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $7.0B100.00% | CVNA ×1.14 |
| Gross profit | 18.92%$1.5B | 17.41%$1.2B | CVNA +1.5pp |
| Operating income | 8.88%$714M | 4.48%$315M | CVNA +4.4pp |
| Pre-tax income | 6.87%$552M | 3.07%$216M | CVNA +3.8pp |
| Net income |
| 6.01%$483M |
| 2.31%$162M |
| CVNA +3.7pp |
No shared counterparties.